Yu Zhang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Nanfang Hospital, Institute of Hematology & Blood Diseases Hospital, Jiangsu Province Hospital, Southern Medical University, Nanjing Medical University · ORCID：0000-0003-0869-9429

发表论文 115 篇 · 总被引 1279 次 · h-index 21

代表论文

Bioorthogonal Disruption of Pyroptosis Checkpoint for High-Efficiency Pyroptosis Cancer Therapy (2023 · Journal of the American Chemical Society · 被引 103)
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial (2023 · Journal of Hematology & Oncology · 被引 72)
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD : A multicenter phase 2 study (2023 · Journal of Internal Medicine · 被引 22)
Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study (2023 · Signal Transduction and Targeted Therapy · 被引 15)
Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study (2023 · Blood Cancer Journal · 被引 14)
Distinct roles for type I and type III interferons in virulent human metapneumovirus pathogenesis (2024 · PLoS Pathogens · 被引 12)